Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aidi injection post-market safety evaluation (100000-case real-world study)
ChiCTR-OPC-16010277Phase 4Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2016
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aidi injection in cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Safety. Started Sep 2016; status: recruiting.
02
Drugs
aidi injection
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR-OPC-16010277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16010277.